CRP and systemic inflammatory response syndrome: Feng et al. described a lower CRP level to controls in the early and late treatment phases and hypothesized a positive effect on SIRS by PXs [68] but Iwase et al. demonstrated evidence of a sustained systemic inflammatory response [54].